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hanges in the Incidence, Clinical
haracteristics, and Indications From 1979 to 2003
ric H. Yang, MD,* Richard J. Gumina, MD, PHD,* Ryan J. Lennon, MS,† David R. Holmes, JR, MD,*
haranjit S. Rihal, MD,* Mandeep Singh, MD*
ochester, Minnesota
OBJECTIVES The purpose of the current study was to evaluate the changes in incidence, clinical
characteristics, and indications for emergency coronary artery bypass grafting (CABG) in
patients undergoing percutaneous coronary intervention (PCI) from 1979 to 2003.
BACKGROUND Emergency CABG after PCI is associated with significant morbidity and mortality.
METHODS Data from 23,087 patients who underwent PCI at Mayo Clinic from 1979 to 2003 were
analyzed. Patients were divided into three groups: the “pre-stent” era, 1979 to 1994 (n 
8,905); the “initial stent era,” 1995 to 1999 (n  7,605); and the “current stent era,” 2000 to
2003 (n  6,577).
RESULTS Although patients undergoing PCI in the recent time periods had more high-risk features,
there was a significant decrease in the incidence of emergency CABG from 2.9% to 0.7% to
0.3% across the groups (p  0.001). Patients requiring emergency surgery in the recent time
periods had a higher prevalence of hypertension, prior revascularization, and left ventricular
dysfunction (ejection fraction 40%), as well as more complex coronary lesions. Fewer
patients in the current stent era had coronary artery dissections and abrupt vessel closure
requiring emergency CABG. The in-hospital mortality rate for emergency CABG patients
remains unchanged and ranges from 10% to 14%.
CONCLUSIONS The current study demonstrates that despite the increase in high-risk patients undergoing
PCI, there has been a marked decrease in the incidence of patients requiring emergency
CABG. However, the in-hospital mortality rate for those requiring emergency CABG
remains high and unchanged. (J Am Coll Cardiol 2005;46:2004–9) © 2005 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.06.083American College of Cardiology Foundation
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aany technologic and pharmacologic advances in percuta-
eous coronary intervention (PCI) have been made over the
ast 25 years. Steerable guide wires, coronary artery stents,
nd new anti-platelet therapies have resulted in an increase
n the success rate of PCI procedures (1–3). In addition,
igh-risk patients who in the past would have undergone
urgical revascularization are now undergoing PCI (4,5).
See page 2010
espite the increase in the number of PCI procedures
erformed, the need for emergency coronary bypass grafting
CABG) has been decreasing (6). Emergency CABG,
owever, still occurs and is associated with significant
orbidity and mortality (7–9). The impact of improvements
n technology and the inclusion of high-risk patients on the
eed and outcome of emergency CABG following PCI are
ot well known.
From the Divisions of *Cardiovascular Disease and Internal Medicine and
Biostatistics, Mayo College of Medicine, Rochester, Minnesota.G
Manuscript received April 11, 2005; revised manuscript received June 10, 2005,
ccepted June 20, 2005.We hypothesized that improvements in PCI technology
nd the inclusion of high-risk patients have resulted in a
hange in the incidence, clinical characteristics, and indica-
ions for emergency CABG in patients undergoing PCI
rom 1979 to 2003.
ETHODS
tudy patients. Patients undergoing PCI at the Mayo
linic have been followed in a prospective registry since
979. Patients in this registry have undergone follow up at
months, 1 year, and then annually since their PCI. A total
f 23,087 patients undergoing PCI from 1979 to 2003 were
ncluded in the study. Patients were divided into three
roups on the basis of the time period of their PCI. Group
consisted of 8,905 patients who underwent PCI from
979 to 1994 and represents the “pre-stent era.” During this
eriod, the technology for percutaneous transluminal angio-
lasty was being developed and operator experience was
eing gained. Group 2 consisted of 7,605 patients under-
oing PCI from 1995 to 1999 and is considered the
early-stent era.” This was a transition period where stents
nd new parentral anti-platelet agents were introduced.
roup 3 included 6,577 patients who underwent PCI from
2
r
m
d
D
s
m
e
a
i
c
n
b
p
C
w
i
l
e
t
a
r
o
c
n
C
A
S
c
K
s
a
c
c
c
0
p
e
s
c
9
R
C
c
f
G
1
G
a
r
7
i
5
t
P
3
2
2005JACC Vol. 46, No. 11, 2005 Yang et al.
December 6, 2005:2004–9 Emergency CABG for PCI000 to 2003 and represents the “current-stent era.” In this
ecent time period, there was more frequent use of bare-
etal stents, parentral glycoprotein IIb/IIIa inhibitors, and
ual oral anti-platelet therapy.
efinitions. Emergency CABG was defined as cardiac
urgery performed within hours of PCI to avoid unnecessary
orbidity or death. This surgery takes precedence over
lective cases. Indications for emergency CABG included
brupt vessel closure, extensive coronary artery dissection,
ncomplete revascularization, coronary perforation, unsuc-
essful dilation, and other situations resulting in hemody-
amic instability and requiring surgical intervention. Unsta-
le angina was defined as new onset of chest pain at rest or
rogression of stable angina to an increased Canadian
ardiovascular Society (CCS) score. Patients presenting
ith chest pain within two months of coronary revascular-
zation were also considered to have unstable angina if the
ast episode of pain occurred within one week of the PCI.
The indication for the index PCI was classified as
lective, urgent, or emergent. Emergent cases were those
hat required PCI within hours of presentation in order to
void significant morbidity and mortality. Urgent cases
equired PCI before discharge from the hospital and usually
ccurred within one to three days after presentation with
hest pain. All other cases were considered elective. Coro-
ary lesions were classified according to the American
Abbreviations and Acronyms
ACC/AHA  American College of
Cardiology/American Heart Association
CABG  coronary artery bypass grafting
CCS  Canadian Cardiovascular Society
PCI  percutaneous coronary intervention
Table 1. Characteristics of Patients Undergoin
Group
1979 to
(n  8,9
Age (yrs) 63.8  1
Male gender (%) 6,453 (
Diabetes mellitus (%) 1,531 (
Hypertension (%) 4,347 (
Body mass index (kg/m2) 27.8  4
Prior PCI (%) 2,067 (
Prior CABG (%) 1,664 (
Unstable angina (%) 6,460 (
Ejection fraction 40% 408 (
Type of PCI
Elective 7,287 (
Urgent 708 (
Emergent 909 (
Calcification in lesion (%) 2,032 (
ACC/AHA type C lesion 1,074 (
Total number of stents placed 0.1  .
Glycoprotein IIb/IIIa used (%) 0 (
*p  0.001 versus Group 1.
ACC/AHA American College of Cardiology/American Hear
PCI  percutaneous coronary intervention.ollege of Cardiology/American Heart Association (ACC/
HA) scoring system (10).
tatistical analysis. Data are presented as mean  SD for
ontinuous variables and frequency for discrete variables.
aplan-Meier methods were used to estimate long-term
urvival. Group comparisons were made using one-way
nalysis of variance for continuous data and Pearson’s
hi-square test for nominal data. Discrete ordinal data were
ompared with the Wilcoxon rank-sum test. For pairwise
omparisons, a Bonferroni-adjusted significance level of
.0167 was used so that the total Type 1 error rate from the
airwise comparisons was no more than 0.05. Predictors of
mergency CABG were determined by using a backwards
election method with multiple logistic regression. Signifi-
ant predictors (p  0.05) were reported as odds ratios and
5% confidence intervals (CI).
ESULTS
haracteristics of patients undergoing PCI. The baseline
haracteristics of the 23,087 patients who underwent PCI
rom 1979 to 2003 are shown in Table 1. Compared to
roup 1, patients in Groups 2 and 3 were older (63.8 
1.4 years vs. 65.5  11.9 years and 66.9  12.1 years for
roup 1 versus Groups 2 and 3, respectively, p  0.001),
nd more likely to have diabetes (17% vs. 22% and 26%,
espectively, p  0.001), hypertension (49% vs. 61% and
4%, respectively, p  0.001), and a greater body mass
ndex (27.8  4.6 kg/m2 vs. 29.0  5.2 kg/m2 and 29.7 
.7 kg/m2, respectively, p  0.001). Patients in the recent
ime periods were also more likely to have undergone prior
CI (23% vs. 32% and 36% for Group 1 vs. Groups 2 and
, respectively, p  0.001) or CABG (19% vs. 21% and
2%, respectively, p  0.001) and were more likely to have
cutaneous Coronary Intervention
Group 2
1995 to 1999
(n  7,605)
Group 3
2000 to 2003
(n  6,577)
65.5  11.9* 66.9  12.1*
5,380 (71) 4,260 (70)
1,700 (22)* 1,697 (26)*
4,559 (61)* 4,613 (74)*
29.0  5.2* 29.7  5.7*
2,429 (32)* 2,369 (36)*
1,619 (21)* 1,474 (22)*
5,084 (67)* 3,739 (57)*
750 (10)* 753 (11)*
* *
2,966 (39) 2,204 (34)
3,355 (44) 3,142 (48)
1,276 (17) 1,228 (19)
2,918 (41)* 1,991 (33)*
3,169 (46)* 2,532 (42)*
1.2  1.1* 1.4  1*
2,593 (34)* 3,907 (59)*g Per
1
1994
05)
1.4
72)
17)
49)
.6
23)
19)
73)
5)
82)
8)
10)
24)
32)
3
0)t Association; CABG coronary artery bypass graft surgery;
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Emergency CABG for PCI December 6, 2005:2004–9n ejection fraction 40% (5% vs. 10% and 11%, respec-
ively, p  0.001). Patients in Groups 2 and 3 were also
ore likely to have calcified (24% vs. 41% and 33% for
roup 1 vs. Groups 2 and 3, respectively, p  0.001) and
ype C coronary lesions (32% vs. 46% and 42%, respectively,
 0.001). Despite a greater percentage of patients
resenting with unstable angina (57% vs. 73% and 67%,
espectively, p 0.001), patients in Group 1 were less likely
han those in Groups 2 and 3 to undergo urgent (8% vs.
4% and 48%, respectively, p  0.001) or emergent proce-
ures (10% vs. 17% and 19%, respectively, p  0.001).
here were a significantly greater proportion of stents used
igure 1. Percentage of patients requiring emergency coronary artery
ypass grafting (CABG) after percutaneous coronary intervention from
979 to 2003 (n  23,087). *Armitage test for trend.
Table 2. Characteristics of Patients Requiring
Percutaneous Coronary Intervention
Grou
1979 to
(n 
Age (yrs) 62.4 
Male gender (%) 181 (
Diabetes mellitus (%) 23 (
Hypertension (%) 98 (
Body mass index (kg/m2) 27.0 
Prior PCI (%) 48 (
Prior CABG (%) 25 (
Unstable angina (%) 187 (
Ejection fraction 40% (%) 14 (
Type of PCI
Elective 210 (
Urgent 10 (
Emergent 38 (
Calcification in lesion (%) 54 (
ACC/AHA type C lesion 15 (
Total number of stents placed 0.1 
Glycoprotein IIb/IIIa used (%) 0 (
Indication for emergency CABG
Abrupt vessel closure 55 (
Dissection 88 (
Incomplete revascularization 26 (
Perforation 1 (
Unsuccessful dilation 67 (
Other 21 (*p  0.05 versus Group 1.
Abbreviations as in Table 1.0.1  0.3 stents/patient vs. 1.2  1.1 and 1.4  1
tents/patient, respectively, p  0.001) and glycoprotein
Ib/IIIa inhibitors (0% vs. 34% and 59%, respectively, p 
.001) in Groups 2 and 3.
n-lab death. The incidences of in-lab death were 35
0.39%) in Group 1, 22 (0.29%) in Group 2, and 15 (0.23%)
n Group 3 (p  0.06 for trend).
haracteristics of patients requiring emergency CABG.
emporal trends in the proportion of patients requiring
mergency CABG are shown in Figure 1. A significant
ecrease in the incidence of emergency CABG from 2.9%
o 0.7% to 0.3% (p  0.001 Armitage test for trend) was
bserved across the three groups. As shown in Table 2,
atients requiring emergency CABG in the recent time
eriods had a higher prevalence of hypertension (39% vs.
6% and 65% for Group 1 vs. Groups 2 and 3, respectively,
 0.010), prior PCI (19% vs. 3% and 24%, p  0.039),
nd left ventricular dysfunction (5% vs. 13% and 24%,
espectively, p  0.004). These patients were also more
ikely than those in Group 1 to have undergone urgent (4%
s. 30% and 38% for Group 1 vs. Groups 2 and 3,
espectively, p  0.001) and emergent (15% vs. 45% and
8%, respectively, p  0.001) procedures and have more
omplex coronary lesions.
During the study period, there was a significant change in
easons for emergency CABG (Table 2). Compared with
he patients in Group 1, those in Groups 2 and 3 had a
ignificantly lower incidence of abrupt vessel closure (21%
rgency Coronary Bypass Surgery After
Group 2
1995 to 1999
(n  56)
Group 3
2000 to 2003
(n  21)
64.6  10.0 53.5  14.9
36 (64) 16 (76)
3 (5) 2 (10)
28 (56)* 13 (65)*
28.4  3.9 30.4  4.3*
19 (34)* 5 (24)*
3 (5) 0 (0)
31 (55)* 13 (62)*
7 (13)* 5 (24)*
* *
14 (25) 5 (24)
17 (30) 8 (38)
25 (45) 8 (38)
30 (61)* 11 (65)*
24 (56)* 9 (50)*
0.9  1.1* 1.1  1.4*
16 (29)* 11 (52)*
2 (4)* 3 (14)*
12 (22)* 3 (14)*
7 (13) 4 (19)
1 (2) 2 (9)
28 (50) 7 (33)
6 (10) 2 (9)Eme
p 1
1994
258)
10.7
70)
9)
39)
4.1
19)
10)
72)
5)
81)
4)
15)
22)
29)
0.4
0)
21)
34)
10)
0.5)
26)
8)
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December 6, 2005:2004–9 Emergency CABG for PCIs. 4% and 14% for Group 1 vs. Groups 2 and 3, respec-
ively, p  0.001) and coronary artery dissection (34% vs.
2% and 14%, respectively, p  0.001) requiring emergency
ABG. Patients requiring emergency CABG in Groups 2
nd 3 were also more likely to have coronary artery stents
laced (0.1  0.4 stents/patient vs. 0.9  1.1 and 1.1  1.4
tents/patient, respectively, p  0.001) and receive glyco-
rotein IIb/IIIa inhibitors (0% vs. 29% and 52%, respec-
ively, p  0.001).
redictors of emergency CABG. During the pre-stent era
1979 to 1994) the strongest predictor for emergency
ABG was pre-procedure shock (OR 2.35, 95% confidence
nterval 1.33 to 4.13). Other significant predictors (Table 3)
ncluded acute myocardial infarction, CCS score 3, lesion
n an angulated segment (45°), and multi-vessel coronary
isease.
During the stent-era (1995 to 2003) the strongest pre-
ictor for emergency CABG was an emergent indication for
CI (odds ratio 3.77, 95% confidence interval 2.02 to 7.02).
ther significant predictors (Table 4) were multi-vessel
oronary artery disease, the presence of peripheral vascular
isease, lesion in an angulated segment (45°), and history
f tobacco abuse.
ortality rate of emergency CABG. Forty-one patients
31 in Group 1, 8 in Group 2, and 2 in Group 3) who had
mergency CABG died during hospitalization. The in-
ospital mortality rates of patients undergoing emergency
ypass surgery are shown in Figure 2 and range from 10% to
4%. There was no significant difference in the mortality
ates between the three groups. The most common causes of
eath (Table 5) were postoperative myocardial infarction
56%) and respiratory failure from pneumonia, acute lung
njury, acute respiratory distress syndrome, or pulmonary
mbolism (19.5%). An unsuccessful PCI attempt was the
ost common indication for emergency CABG in these
atients (53.7%).
able 3. Predictors for Emergency Coronary Artery Bypass
rafting During the Pre-Stent Era (1979 to 1994)
Odds Ratio 95% CI
re-procedure shock 2.35 1.33–4.13
cute myocardial infarction 1.82 1.31–2.53
anadian Cardiovascular
Society angina class 3
1.81 1.35–2.42
ngulated segment (45°) 1.66 1.27–2.17
ulti-vessel coronary disease 1.55 1.18–2.04
I  confidence interval.
able 4. Predictors for Emergency Coronary Artery Bypass
rafting During the Stent Era (1995 to 2003)
Odds Ratio 95% CI
mergent PCI 3.77 2.02–7.02
ulti-vessel coronary disease 2.40 1.44–4.0
eripheral vascular disease 2.28 1.24–4.17
ngulated segment (45°) 1.90 1.19–3.03
istory of smoking 1.88 1.07–3.28I  confidence interval; PCI  percutaneous coronary intervention.
V
rne-year outcomes. In Groups 1, 2, and 3, respectively,
27, 48, and 19 patients who had emergency CABG
urvived to hospital discharge. The 1-year survival rates
ere similar in these patients (94.3%, 97.9%, and 87.7%).
ISCUSSION
he current study demonstrates that despite the increase in
igh-risk patients undergoing PCI, there has been a signif-
cant and sustained decrease in the incidence of emergency
ABG. There has also been a change in the indication for
mergency CABG, with fewer abrupt vessel closures and
oronary artery dissections. These changes are likely due to
mprovements in interventional technology and medical
herapy. The in-hospital mortality rate for those requiring
mergency CABG, however, is unchanged and remains
igh.
haracteristics of patients undergoing PCI. Our results
how that older and sicker patients are undergoing PCI.
atients in the more recent time periods were more likely to
ave hypertension, diabetes, and left ventricular dysfunc-
ion. Angiographically, these patients also had higher risk
oronary disease with greater calcification and more severe
CC/AHA lesion scores. Similar findings were noted in a
rior study involving patients from the National, Heart,
ung, and Blood Institute Registry (4). A possible expla-
ation for the increase in high-risk patients is that the
igure 2. In-hospital mortality rates of patients requiring emergency
oronary artery bypass grafting after percutaneous coronary intervention
rom 1979 to 2003 (n  335).
able 5. Cause of Death and Indication for Bypass Surgery in
1 Patients With In-Hospital Death After Emergency Surgery
ause of death
Postoperative myocardial infarction 23 (56)
Cardiac arrhythmia 8 (19.5)
Respiratory failure 5 (12.1)
Heart failure 3 (7.3)
Cerebrovascular accident 1 (2.4)
Ventricular rupture 1 (2.4)
ndication for CABG
Unsuccessful dilation 22 (53.7)
Dissection 5 (12.2)
Incomplete revascularization 5 (12.2)
Abrupt vessel closure 3 (7.1)alues are n (%). Respiratory failure includes pneumonia, acute lung injury, acute
espiratory distress syndrome, and pulmonary embolism.
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Emergency CABG for PCI December 6, 2005:2004–9idespread use of coronary artery stenting has resulted in an
mprovement in PCI outcomes. These improvements may
ave allowed more high-risk patients to undergo PCI.
Although more high-risk patients are undergoing PCI,
he in-lab death rate has remained the same. This finding,
long with the decrease in emergency PCI rates, suggests
hat improvements in PCI have resulted in fewer compli-
ations, but if a major complication occurs, the mortality
ate remains unchanged by the newer technologies.
ncidence of emergency CABG. Despite the increase in
igh-risk patients undergoing PCI, we found a 10-fold
eduction in the incidence of emergency CABG, from 2.9%
o 0.3%. These data are similar to the rates reported by
eshadri et al. (6) from the Cleveland Clinic, who reported
rate of 0.61%. Our results are also consistent with those
rom six trials comparing coronary artery stenting to angio-
lasty. This analysis demonstrated that 0.31% of patients in
he most recent time period undergoing primary PCI
equired emergency CABG (11). The decline in the inci-
ence of emergency CABG is most likely due to the
evelopment of coronary artery stents and glycoprotein
Ib/IIIa inhibitors (12,13).
The patients requiring emergency CABG in the current-
tent era were also older and sicker than the patients in the
re-stent era. This may be a reflection of the increase in
igh-risk patients undergoing PCI.
ndications for emergency CABG. There was a significant
hange in the indications for emergency CABG after PCI,
ith a decrease in the incidence of abrupt vessel closure and
oronary artery dissection resulting in the need for emergency
ABG. Both of these changes are most likely due to the
ncreased use of coronary artery stents and glycoprotein IIb/
IIa inhibitors, which reduce the risk of abrupt vessel closure
nd can be used to treat coronary artery dissections (14).
There has also been a change in the predictors of
mergency CABG. In the pre-stent era, the presence of
re-procedural shock was the strongest predictor. In the
tent era, shock is no longer a significant predictor and again
ay be due to improvements in PCI technology.
utcomes of emergency CABG. Although there has been
change in the characteristics and indications for emer-
ency CABG, the in-hospital and one-year mortality rate
or these patients remains the same, underscoring the need
o recognize variables associated with higher incidence of
mergent CABG, and tailor strategies to avoid or reduce such
omplication. We observed a mortality rate of 10% to 14%,
hich is similar to the rate of 15% reported by Seshadri et
l. (6). These rates are much higher than those for elective
ABG, and a previous study suggests that the high mor-
ality rate may be due to the hemodynamic instability that is
resent at the time of emergency surgery (15). This insta-
ility can lead to a lower probability of receiving an internal
ammary graft and a greater requirement for inotropic
upport and blood products (15,16). The most common
auses of death in these patients were postoperative myo-
ardial infarction and cardiac arrhythmias. EmergencyABG has also been associated with longer hospital stays,
ncreased risk of postoperative myocardial infraction, and a
reater prevalence of ventricular arrhythmias (16).
tudy limitations. A limitation of the current study is that
t was a retrospective review of outcomes at a single high-
olume center. The results may therefore not be applicable
o other centers with lower volumes.
onclusions. In conclusion, the results of the current study
how that despite the increase in high-risk patients under-
oing PCI, there has been a dramatic decrease in the
ncidence of patients requiring emergency CABG. In addi-
ion, there has been a change in the indication for emer-
ency CABG, with a decrease in the incidence of coronary
rtery dissections and abrupt vessel closure. The mortality
ate associated with emergency CABG, however, remains
igh and unchanged.
eprint requests and correspondence: Dr. Mandeep Singh,
ivision of Cardiovascular Disease and Internal Medicine, Mayo
ollege of Medicine, 200 First Street SW, Rochester, Minnesota
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